Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3
1(100.0%)
1Total
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05965687Phase 3Recruiting

Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke (OPENS-3)

Role: collaborator

NCT06276790Completed

Objective Analysis of Caesarean Scar Pregnancy

Role: lead

NCT03193879Completed

Effects of Particulate Matter on the Pulmonary Function and Acute Exacerbation of COPD and Asthma

Role: collaborator

NCT03851497Completed

Application of Deep-learning and Ultrasound Elastography in Opportunistic Screening of Breast Cancer

Role: collaborator

All 4 trials loaded